Shenzhen Kangtai Biological Products Co.Ltd(300601) : minhai biological vaccine industry base (phase II) has been put into operation, and 23 valent pneumococcal polysaccharide vaccine and 13 valent pneumococcal conjugate vaccine have been listed

Every AI express, investors ask questions on the investor interaction platform: Hello Dong min, is it appropriate for your company not to reply to investors’ questions for more than half a month? How is the construction progress of Beijing minhai phase II? Has it been put into operation?

Shenzhen Kangtai Biological Products Co.Ltd(300601) (300601. SZ) said on the investor interaction platform on January 29 that the company has been actively communicating with the majority of investors. The company has specially assigned someone to answer the questions on the interactive platform. Minhai biological vaccine industry base (phase II) has been put into operation, and its 23 price pneumococcal polysaccharide vaccine and 13 price pneumococcal conjugate vaccine have been put on the market.

- Advertisment -